US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist
  • 4.970
  • +0.120+2.47%
Close Nov 25 16:00 ET
  • 4.970
  • 0.0000.00%
Post 16:47 ET
295.96MMarket Cap-6626P/E (TTM)

Aldeyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aldeyra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 1.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 1.000M--

Unlock Free Earnings Estimates

Aldeyra Therapeutics Earnings Reports

  • Aldeyra Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 16:04 ET

  • Aldeyra Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:10 ET

  • Aldeyra Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 2 16:10 ET

  • Aldeyra Therapeutics | 10-K: FY2023 Annual Report

    Mar 7 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 18, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data